Nizatidine Oral Capsule 150Mg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • Weekly Ad

Nizatidine: Oral capsule (150mg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file DrugItem_879.JPG
Nizatidine 150mg Cap
Mylan Pharmaceuticals Inc
Pill Identification: MYLAN 5150 MYLAN 5150 
Drug Image file DrugItem_2018.JPG
Nizatidine 150mg Cap
Actavis Inc. formerly Watson Pharmaceuticals Inc
Pill Identification: 3137 WPI 
Drug Image file DrugItem_4855.JPG
Nizatidine 150mg Cap
Eon Labs Inc a Division of Sandoz
Pill Identification: E150 E150 

What is this Medicine?

NIZATIDINE (ni ZA ti deen) is a type of antihistamine that blocks the release of stomach acid. It is used to treat stomach or intestinal ulcers. It can relieve ulcer pain and discomfort, and the heartburn from acid reflux.

CVS Pharmacy Patient Statistics for Nizatidine: Oral capsule(150mg)
Generic vs. Brand Name Usage*
*Brand contains same active ingredient but may not represent FDA-approved generic equivalent
Usage By Strength
In-Depth Information
Select a Medication

Nizatidine 150mg Capsule

NDC: 003785150
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Esophagitis, Helicobacter Pylori (H. Pylori) Eradication, Gastric Ulcer, Duodenal Ulcer, Gastroesophageal Reflux Disease (GERD)

Sometimes used for but not FDA approved for the following conditions:
Aspiration Prophylaxis, Stress Gastritis Prophylaxis

Storage Information
Store at room temperature (between 59 to 86 degrees F)
Nizatidine 150mg Capsule
Drug Image file DrugItem_879.JPG
Mylan Pharmaceuticals Inc
Pill Identification: MYLAN 5150 MYLAN 5150 
Shape: capsule
Color: purple

Reported Side Effects for Nizatidine 150mg Capsule

Rapid Heart Rate Incidence:
<1.0%*
Severity: SEVERE
Onset: EARLY
Cholestasis Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Liver Infection Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Yellow Skin Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Convulsions Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Inflamed Blood Vessels Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Anaphylactoid Reactions Incidence:
<1.0%*
Severity: SEVERE
Onset: RAPID
Breathing Difficulties Incidence:
<1.0%*
Severity: SEVERE
Onset: RAPID
Confusion Incidence:
<1.0%*
Severity: MODERATE
Onset: EARLY
Elevated Hepatic Enzymes Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Eosinophilia Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Gynecomastia Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
Impotence (erectile Dysfunction) Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Laryngeal Edema Incidence:
<1.0%*
Severity: SEVERE
Onset: RAPID
Bruises Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
Skin Rash Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Low Platelet Count Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Exfoliative Dermatitis Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
High Uric Acid Level Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Serum Sickness Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Anemia Incidence:
0.2%*
Severity: MODERATE
Onset: DELAYED
Hives Incidence:
0.5%*
Severity: MILD
Onset: RAPID
Lazy Eye Incidence:
1.0%*
Severity: MODERATE
Onset: DELAYED
Dry Mouth Incidence:
1.4%*
Severity: MILD
Onset: EARLY
Muscle Pain Incidence:
1.7%*
Severity: MILD
Onset: EARLY
Infection Incidence:
1.7%*
Severity: MILD
Onset: DELAYED
Itching Incidence:
1.7%*
Severity: MILD
Onset: RAPID
Nervousness Incidence:
1.8%*
Severity: MILD
Onset: DELAYED
Drowsiness Incidence:
1.9%*
Severity: MILD
Onset: EARLY
Chest Pain Incidence:
2.3%*
Severity: MODERATE
Onset: EARLY
Sinus Infection Incidence:
2.4%*
Severity: MILD
Onset: DELAYED
Sore Throat Incidence:
>3.3%*
Severity: MILD
Onset: DELAYED
Lightheadedness Incidence:
4.6%*
Severity: MILD
Onset: EARLY
Stuffy Nose Incidence:
>5.0%*
Severity: MILD
Onset: EARLY
Vomiting Incidence:
>5.0%*
Severity: MILD
Onset: EARLY
Fever Incidence:
>5.0%*
Severity: MILD
Onset: EARLY
Irritability Incidence:
>5.0%*
Severity: MILD
Onset: DELAYED
Loose Stools Incidence:
>5.0%*
Severity: MILD
Onset: EARLY
Cough Incidence:
>5.0%*
Severity: MILD
Onset: DELAYED
Rhinitis Incidence:
9.8%*
Severity: MILD
Onset: EARLY
Headache Incidence:
16.6%*
Severity: MILD
Onset: EARLY
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Daily Life Interactions for Nizatidine 150mg Capsule

Elements of your daily lifestyle may have an effect on the medications you are taking. Drug interactions can result in unwanted side effects, reduce the effectiveness of your medicine or possibly increase the action of a particular medicine.

Minor Lifestyle Interaction
Alcohol and Nizatidine 150mg Capsule(Nizatidine)
Alcohol and H2-blockers(Nizatidine)
Side effects from drinking alcohol-containing drinks may get worse if you take H2-blockers such as cimetidine, famotidine, nizatidine, and ranitidine. Avoid or minimize your intake of alcohol-containing drinks while taking H2-blockers.
Pregnancy & Lactation Information
FIRST Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

SECOND Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

THIRD Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

Lactation

Caution - Not enough information is available to rule out harm to infants when this drug is taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Nizatidine

We want to help you stay educated about the medications you are taking. View other
patient's observations and share your own.

Be sure to consult your health care provider before taking any medications. Other
patient's comments should not be considered medical advice or health care provider
recommendations.